The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have jointly developed Guiding principles of good AI practice in drug...

PlaqueTec and the Babraham Institute are developing a cell phenotyping assay to investigate coronary artery samples from participants in the BIOPATTERN trial and advance research into precision approaches to coronary artery disease.